Abe Oncology Clinic: Personalized Multivalent Dendritic Cell Vaccine and Photoimmunotherapy
Medical Supporter — Information Notice
This article is a summary of international medical information and is not medical advice; it cannot replace the diagnosis or treatment plan of your attending physician. The medical technologies, drug information and clinical data presented here are compiled from public literature and official statements of major Japanese medical institutions; the applicability and outcome of any therapy vary with each patient and must be assessed individually by a qualified physician.
Director abe
Abe Oncology Clinic is a leader in cancer vaccine research in Japan and globally. Founded by Dr. Hiroyuki Abe, the clinic aims to establish a precision medical system that activates the body's self-healing power rather than relying on high-side-effect chemotherapy.
Core Technologies: ABeVax and PIT
- 5th Generation ABeVax Vaccine: This patented technology requires only a small sample of 25ml of blood to prepare a high-quality multivalent dendritic cell vaccine, placing minimal burden on the body.
- Near-Infrared Photoimmunotherapy (PIT): Utilizes specific laser wavelengths to precisely burst tagged cancer cells, triggering a systemic immune response.
【Medical Supporter Guardian Statement】 Medical Supporter was formerly certified as a medical visa guarantor by Japan's Ministry of Foreign Affairs and the Ministry of Economy, Trade and Industry (B-066).
Considering medical care in Japan? Need information and support?
We help you organize the information needed for medical travel to Japan, liaise with Japanese medical institutions, and arrange a second-opinion consultation.The first consultation is free; an advisor will help you clarify the next steps.